Sfoglia per Autore
SUBCUTANEOUS CAMPATH-1H IN REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: FEASIBILITY AND EFFICACY
2003 S. CIOLLI; F. GIGLI; R. FANCI; A. GROSSI; G. LONGO; L. RIGACCI; A. BOSI; F. MANNELLI
High response rates and reduced first dose reactions with subcutaneous alemtuzumab in patients with relapsed and refractory CLL
2003 S. Ciolli ; F. Gigli; F. Mannelli ; R. Fanci ; A. Grossi ; G. Longo ; L. Rigacci ; A. Bosi
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.
2003 P. BONANNI; G. PESAVENTO; A. BECHINI; E. TISCIONE; F. MANNELLI; C. BENUCCI; A. LO NOSTRO
Chronic relapsing thrombotic thrombocytopenic purpura succesfully treated with rituximab: case report
2005 E. ANTONIOLI; A. VANNUCCHI; A. BOSI; G. GIANFALDONI; F. MANNELLI
Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report.
2005 Gianfaldoni, G; Antonioli, E; Mannelli, F; Vannucchi, Am; Bosi, A.
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control
2005 P. BONANNI; BECHINI A; PESAVENTO G; BOCCALINI S; TISCIONE E; GRAZIANI G; SANTINI M.G; BALOCCHINI E; PECORI L; PERUZZI M; MANNELLI F; TOMASI A; MONTOMOLI E
Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma
2005 Antonioli, E; Nozzoli, C; Gianfaldoni, G; Mannelli, F; Rossi, S; Betti, S; Bernardeschi, P; Fiorentini, G; Bosi, Alberto
Progress in Italy in control and elimination of measles and congenital rubella.
2006 P. BONANNI; A. BECHINI; S. BOCCALINI; G. BONCOMPAGNI; F. MANNELLI; M. PERUZZI; F. ANSALDI; ML. CIOFI DEGLI ATTI
Implementazione del piano per l'eliminazione del morbillo e della rosolia congenita in Toscana: progressi verso la seconda fase di controllo dell'infezione.
2006 BECHINI A; PESAVENTO G; BOCCALINI S; TISCIONE E; BALOCCHINI E; GRAZIANI G; PECORI L; SANTINI MG; AZZARI C; PERUZZI M; MANNELLI F; TOMASI A; MONTOMOLI E; MAZZOLI F; P. BONANNI
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients.
2006 V. Ponziani;G. Gianfaldoni;F. Mannelli;F. Leoni;S. Ciolli;P. Guglielmelli;E. Antonioli;G. Longo;A. Bosi;A. M. Vannucchi
Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study.
2006 GIANFALDONI G; MANNELLI F; M. BACCINI; ANTONIOLI E; LEONI F; BOSI A
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).
2007 Paola Guglielmelli; Roberta Zini; Costanza Bogani; Simona Salati; Alessandro Pancrazzi; Elisa Bianchi; Francesco Mannelli; Sergio Ferrari; Marie-Caroline Le Bousse-Kerdilès; Alberto Bosi; Giovanni Barosi; Anna Rita Migliaccio; Rossella Manfredini; Alessandro M Vannucchi
Progress in Italy in control and elimination of measles and congenital rubella.
2007 P. BONANNI; A. BECHINI; S. BOCCALINI; M. PERUZZI; E. TISCIONE; F. MANNELLI; G. BONCOMPAGNI; S. SALMASO; A. FILIA; M. CIOFI DEGLI ATTI
Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.
2008 Schubert, J; Hillmen, P; Röth, A; Young, Ns; Elebute, Mo; Szer, J; Gianfaldoni, G; Socié, G; Browne, P; Geller, R; Rother, Rp; Muus, P; Antonioli, E; Mannelli, F; Bosi, A; Rodeghiero, F
No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia.
2008 V. Ponziani; F. Mannelli; N. Bartalucci; G. Gianfaldoni; F. Leoni; E. Antonioli; P. Guglielmelli; S. Ciolli; A. Bosi; A. M. Vannucchi
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.
2008 Gianfaldoni, G; Mannelli, F; Bencini, S; Leoni, F; Baldini, S; Bosi, Alberto
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.
2008 Gianfaldoni G;Mannelli F;Bencini S;Leoni F;Baldini S;Bosi A
High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients.
2009 B.Scappini; G. Gianfaldoni; P. Salvatore; MC. Susini; T. Izzo; F. Mannelli; G. Longo; R. Fanci; F. Ferrara; A. Bosi
High dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-Myl) in relapsed or refractory AML patients
2009 B. Scappini; G. Gianfaldoni; MC. Susini; R. Fanci; S. Baldini; R. Fjerza; F. Mannelli; G. Longo; A. Bosi
Atypical acute leukemia early after liver transplantation.
2009 Mannelli, F; De Simone, P; Gianfaldoni, G; Nozzoli, C; Filipponi, F; Bosi, Alberto
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
SUBCUTANEOUS CAMPATH-1H IN REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: FEASIBILITY AND EFFICACY | 2003 | S. CIOLLI; F. GIGLI; R. FANCI; A. GROSSI; G. LONGO; L. RIGACCI; A. BOSI; F. MANNELLI | |
High response rates and reduced first dose reactions with subcutaneous alemtuzumab in patients with relapsed and refractory CLL | 2003 | S. Ciolli ; F. Gigli; F. Mannelli ; R. Fanci ; A. Grossi ; G. Longo ; L. Rigacci ; A. Bosi | |
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. | 2003 | P. BONANNI; G. PESAVENTO; A. BECHINI; E. TISCIONE; F. MANNELLI; C. BENUCCI; A. LO NOSTRO | |
Chronic relapsing thrombotic thrombocytopenic purpura succesfully treated with rituximab: case report | 2005 | E. ANTONIOLI; A. VANNUCCHI; A. BOSI; G. GIANFALDONI; F. MANNELLI | |
Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report. | 2005 | Gianfaldoni, G; Antonioli, E; Mannelli, F; Vannucchi, Am; Bosi, A. | |
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control | 2005 | P. BONANNI; BECHINI A; PESAVENTO G; BOCCALINI S; TISCIONE E; GRAZIANI G; SANTINI M.G; BALOCCHINI E; PECORI L; PERUZZI M; MANNELLI F; TOMASI A; MONTOMOLI E | |
Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma | 2005 | Antonioli, E; Nozzoli, C; Gianfaldoni, G; Mannelli, F; Rossi, S; Betti, S; Bernardeschi, P; Fiorentini, G; Bosi, Alberto | |
Progress in Italy in control and elimination of measles and congenital rubella. | 2006 | P. BONANNI; A. BECHINI; S. BOCCALINI; G. BONCOMPAGNI; F. MANNELLI; M. PERUZZI; F. ANSALDI; ML. CIOFI DEGLI ATTI | |
Implementazione del piano per l'eliminazione del morbillo e della rosolia congenita in Toscana: progressi verso la seconda fase di controllo dell'infezione. | 2006 | BECHINI A; PESAVENTO G; BOCCALINI S; TISCIONE E; BALOCCHINI E; GRAZIANI G; PECORI L; SANTINI MG; AZZARI C; PERUZZI M; MANNELLI F; TOMASI A; MONTOMOLI E; MAZZOLI F; P. BONANNI | |
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients. | 2006 | V. Ponziani;G. Gianfaldoni;F. Mannelli;F. Leoni;S. Ciolli;P. Guglielmelli;E. Antonioli;G. Longo;A. Bosi;A. M. Vannucchi | |
Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study. | 2006 | GIANFALDONI G; MANNELLI F; M. BACCINI; ANTONIOLI E; LEONI F; BOSI A | |
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). | 2007 | Paola Guglielmelli; Roberta Zini; Costanza Bogani; Simona Salati; Alessandro Pancrazzi; Elisa Bianchi; Francesco Mannelli; Sergio Ferrari; Marie-Caroline Le Bousse-Kerdilès; Alberto Bosi; Giovanni Barosi; Anna Rita Migliaccio; Rossella Manfredini; Alessandro M Vannucchi | |
Progress in Italy in control and elimination of measles and congenital rubella. | 2007 | P. BONANNI; A. BECHINI; S. BOCCALINI; M. PERUZZI; E. TISCIONE; F. MANNELLI; G. BONCOMPAGNI; S. SALMASO; A. FILIA; M. CIOFI DEGLI ATTI | |
Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. | 2008 | Schubert, J; Hillmen, P; Röth, A; Young, Ns; Elebute, Mo; Szer, J; Gianfaldoni, G; Socié, G; Browne, P; Geller, R; Rother, Rp; Muus, P; Antonioli, E; Mannelli, F; Bosi, A; Rodeghiero, F | |
No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia. | 2008 | V. Ponziani; F. Mannelli; N. Bartalucci; G. Gianfaldoni; F. Leoni; E. Antonioli; P. Guglielmelli; S. Ciolli; A. Bosi; A. M. Vannucchi | |
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia. | 2008 | Gianfaldoni, G; Mannelli, F; Bencini, S; Leoni, F; Baldini, S; Bosi, Alberto | |
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia. | 2008 | Gianfaldoni G;Mannelli F;Bencini S;Leoni F;Baldini S;Bosi A | |
High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients. | 2009 | B.Scappini; G. Gianfaldoni; P. Salvatore; MC. Susini; T. Izzo; F. Mannelli; G. Longo; R. Fanci; F. Ferrara; A. Bosi | |
High dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-Myl) in relapsed or refractory AML patients | 2009 | B. Scappini; G. Gianfaldoni; MC. Susini; R. Fanci; S. Baldini; R. Fjerza; F. Mannelli; G. Longo; A. Bosi | |
Atypical acute leukemia early after liver transplantation. | 2009 | Mannelli, F; De Simone, P; Gianfaldoni, G; Nozzoli, C; Filipponi, F; Bosi, Alberto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile